Madeleine is a Melbourne based senior customer strategy and business transformation leader at global health care organisation Bupa. She has a depth of commercial experience gained from working across complex matrix organisations in corporate strategy, marketing, business development, and P&L management. In her current role as Head of Accelerated Growth, Madeleine works to support the development and design of new health and insurance products to support emerging customer needs.
Prior to joining Bupa, Madeleine held a number of commercial leadership roles at Medibank including leading the Corporate Health Insurance and Health and Wellbeing business, supporting organisations and universities to deliver health programs to improve the health of students and employees. Whilst working for the Shell company of Australia, Madeleine lead the introduction of Shell’s Low Aromatic Unleaded petrol with the Australian Federal Government to help prevent negative health issues in northern communities.
Madeleine has a Bachelor of Commerce (Honours) degree from Monash University and a Diploma of Leadership and Management from Swinburne University. She has been on the board of Allergy and Anaphylaxis since 2018.
Madeleine is passionate about health, wellbeing and ensuring customers and communities have access to easy-to-understand health information, so as to support better health outcomes.
Our people
Allergy & Anaphyalxis Austraila is able to carry out its vision and purpose thanks to the generosity of our governing board, and the commitment and dedication of our incredible staff.